Phibro Animal Health Corporation Class A (PAHC) Stock Price

PAHCStock

$37.67−2.05%52W

Market Cap$1.53B

P/E28.63x

PEG Ratio1.68

Div yield4.55%

Beta0.42

PAHC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-38.73%

Price vs S&P 500 (4W)-0.14%

PEG Ratio1.68

VGM Score60.29

P/E Ratio (Annual)28.63x

Indicated Dividend Yield (Annual)4.55%

P/CF (Annual)17.24x

Book Value / Share (Quarterly)$8.92

P/TBV (Annual)4.15x

Indicated Dividend (Annual)$0.48

Revenue Growth (3Y)11.21%

Cash Flow / Share (Quarterly)$0.31

Payout Ratio (TTM)20.43%

Price vs S&P 500 (YTD)-11.99%

Gross Margin (TTM)32.83%

Net Profit Margin (TTM)6.35%

EPS (TTM)$2.33

10-Day Avg Trading Volume0.24M

EPS Excl Extra (TTM)$2.33

Revenue Growth (5Y)10.12%

EPS (Annual)$1.19

Dividend / Share (Annual)$0.48

ROI (Annual)4.81%

Gross Margin (Annual)31.59%

Net Profit Margin (5Y Avg)3.81%

Cash / Share (Quarterly)$1.91

P/E Basic Excl Extra (TTM)14.51x

Revenue Growth QoQ (YoY)10.27%

EPS Growth (5Y)7.42%

P/E Normalized (Annual)28.63x

ROA (Last FY)3.55%

Revenue Growth TTM (YoY)25.98%

EBITD / Share (TTM)$5.64

ROE (5Y Avg)14.19%

Operating Margin (TTM)12.00%

Cash Flow / Share (Annual)$1.03

P/B Ratio3.82x

P/B Ratio (Quarterly)6.20x

Net Income / Employee (Annual)$19,500

EV / Revenue (TTM)1.37x

Net Interest Coverage (TTM)2.60x

ROA (TTM)6.81%

EPS Growth QoQ (YoY)14.14%

EV / EBITDA (TTM)8.95x

EPS Incl Extra (Annual)$1.19

Current Ratio (Annual)2.76x

Quick Ratio (Quarterly)1.26x

3-Month Avg Trading Volume0.32M

52-Week Price Return-2.05%

EV / Free Cash Flow (Annual)49.30x

P/E Incl Extra (TTM)14.51x

Revenue / Employee (TTM)$606,100

Tangible BV / Share (Quarterly)$8.14

P/S Ratio (Annual)1.07x

Asset Turnover (Annual)0.95x

52-Week High$60.08

Operating Margin (5Y Avg)7.69%

EPS Excl Extra (Annual)$1.19

CapEx CAGR (5Y)2.38%

Tangible BV CAGR (5Y)16.29%

26-Week Price Return-26.80%

Quick Ratio (Annual)1.25x

13-Week Price Return18.35%

Total Debt / Equity (Annual)2.52x

Current Ratio (Quarterly)3.17x

Enterprise Value$2.06B

Revenue / Share Growth (5Y)10.03%

Asset Turnover (TTM)1.07x

Book Value / Share Growth (5Y)8.69%

Revenue / Employee (Annual)$523,700

Inventory Turnover (Annual)2.50x

Pretax Margin (Annual)5.25%

Cash / Share (Annual)$1.90

3-Month Return Std Dev42.11%

Gross Margin (5Y Avg)31.15%

Net Income / Employee (TTM)$38,500

EBITDA CAGR (5Y)8.98%

EBITDA Interim CAGR (5Y)15.30%

ROE (Last FY)16.89%

Net Interest Coverage (Annual)3.52x

EPS Basic Excl Extra (Annual)$1.19

P/FCF (TTM)79.98x

Receivables Turnover (TTM)7.16x

EV / Free Cash Flow (TTM)161.48x

Total Debt / Equity (Quarterly)2.03x

EPS Incl Extra (TTM)$2.33

Receivables Turnover (Annual)6.52x

ROI (TTM)9.03%

Dividend Growth Rate (5Y)0.02%

P/S Ratio (TTM)0.92x

Pretax Margin (5Y Avg)5.50%

Revenue / Share (Annual)$31.87

Tangible BV / Share (Annual)$6.15

Forward P/E10.94x

Free OCF CAGR (5Y)10.58%

Price vs S&P 500 (52W)-20.61%

P/E Ratio (TTM)14.51x

EPS Growth TTM (YoY)197.88%

Year-to-Date Return0.83%

5-Day Price Return6.68%

EPS Normalized (Annual)$1.19

ROA (5Y Avg)3.78%

Net Profit Margin (Annual)3.72%

Month-to-Date Return3.69%

Cash Flow / Share (TTM)$1.36

EBITD / Share (Annual)$3.84

EPS Growth (3Y)-0.78%

Operating Margin (Annual)8.52%

LT Debt / Equity (Annual)2.46x

P/CF (TTM)20.89x

ROI (5Y Avg)5.03%

P/E Excl Extra (TTM)14.51x

LT Debt / Equity (Quarterly)1.97x

EPS Basic Excl Extra (TTM)$2.33

P/TBV (Quarterly)6.79x

Payout Ratio (Annual)40.30%

P/B Ratio (Annual)3.62x

Dividend / Share (TTM)$0.48

Inventory Turnover (TTM)2.04x

Pretax Margin (TTM)8.59%

Book Value / Share (Annual)$7.05

Price vs S&P 500 (13W)16.39%

Net Margin Growth (5Y)-2.40%

Dividend Yield (TTM)1.41%

Beta0.42x

P/FCF (Annual)33.03x

Revenue / Share (TTM)$36.55

ROE (TTM)29.49%

52-Week Low$28.25

vGradeC

gGradeB

mGradeB

vgmGradeB

PAHC Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 26, 2026	$0.73	$0.85	+17.08%(+$0.12)
Q1 2026	May 6, 2026	$0.71	$0.76	+6.52%(+$0.05)
Q4 2025	Feb 4, 2026	$0.67	$0.87	+29.85%(+$0.20)
Q3 2025	Nov 5, 2025	$0.60	$0.73	+21.09%(+$0.13)
Q2 2025	Aug 27, 2025	$0.52	$0.57	+9.35%(+$0.05)

PAHC Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.50

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
PAHCPhibro Animal Health Corporation Class A	C	B	B	$37.67
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About Phibro Animal Health Corporation Class A

Phibro Animal Health Corp provides diversified animal health and mineral nutrition products for food-producing animals including poultry, swine, beef cattle, dairy cattle, and aquaculture. The company manufactures and markets antibacterials, anticoccidials, vaccines, and specialty nutritional products through three segments: Animal Health (its primary revenue driver), Mineral Nutrition, and Performance Products. The company operates in the United States and international markets.